Samsung Biologics' Accounting Violation's Impact on Samsung C&T and Rest of the Korean Pharmas
On May 1st, 2018, Korea's Financial Supervisory Service (FSS) announced that Samsung Biologics Co., Ltd (207940 KS) violated accounting rules after...
309 Views
SK Group Restructuring - Local Institutions Are Already Making A Move
We are now seeing a very interesting move from Korea's local institutions on those SK Group restructuring stocks. Last week, to be specific from...
430 Views
Foreign Investors Vs. Local Institutions in Korean Stock Market - Who Is Right?
Last month, foreign investors went on a buying spree in the Korea's second largest stock market, KOSDAQ. In contrast, they went on a selling spree...
1.2k Views
How Will South Korea Change With Moon as Its Next President? (Top 10 Issues)
Bonifas and Barrett may not be household names to most people. They were two US Army officers stationed in South Korea who were killed by North...
453 Views
Yuhan Corp: (Part I) - Oversold on Hanmi Pharma Scares
Why Look atYuhan Corp?Yuhan Corp shares are quite interesting at current levels. It is currently trading at 214,000 won, which is down 38% (A...
1.4k Views